Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms Degronimer 1 |
Target |
Mechanism BRD4 degraders(Bromodomain-containing protein 4 degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC42H52ClN9O3S |
InChIKeyKAFZWFVFEFZAKD-HTIIIDOHSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | US | 15 Feb 2019 |